Nicky Dunn

Publications
CV
Public outreach and news

Articles

Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2022;63:103815
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta
Querejazu MO; Dunn N; Ramanujam R; Ryner M; Auer M; Jensen PEH; Deisenhammer F; Fogdell-Hahn A; Behalf ABIRISK consortium ABIRISK
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:826152
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
Faustini F; Sippl N; Stalesen R; Chemin K; Dunn N; Fogdell-Hahn A; Gunnarsson I; Malmstroem V
Article: ARTHRITIS RESEARCH & THERAPY. 2021;23(1):211
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis
Faustini F; Dunn N; Kharlamova N; Ryner M; Bruchfeld A; Malmstrom V; Fogdell-Hahn A; Gunnarsson I
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:666114
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases
Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Ronnelid J; Pullerits R; Gjertsson I; Lundberg K; Manberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2020;92(6):e12984
The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy
Dunn N; Kharlamova N; Fogdell-Hahn A
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:1365
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier
Kharlamova N; Hermanrud C; Dunn N; Ryner M; Hambardzumyan K; Pomiano NV; Marits P; Gjertsson I; Saevarsdottir S; Pullerits R; Fogdell-Hahn A
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:583560
Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
Dunn N; Fogdell-Hahn A; Hillert J; Spelman T
Article: MULTIPLE SCLEROSIS JOURNAL. 2018;24(9):1224-1233
Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
Dunn N; Juto A; Ryner M; Manouchehrinia A; Piccoli L; Fink K; Piehl F; Fogdell-Hahn A
Article: JOURNAL OF VIROLOGY. 2017;91(11):10.1128/jvi.02105-10.1128/jvi.02116
Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration
Engdahl E; Dunn N; Niehusmann P; Wideman S; Wipfler P; Becker AJ; Ekstrom TJ; Almgren M; Fogdell-Hahn A
Article: JOURNAL OF VIROLOGICAL METHODS. 2016;227:47-49
Investigation of reference gene expression during human herpesvirus 6B infection indicates peptidylprolyl isomerase A as a stable reference gene and TATA box binding protein as a gene up-regulated by this virus
Engdahl E; Dunn N; Fogdell-Hahn A

All other publications

Review: ACTA NEUROLOGICA SCANDINAVICA. 2022;145(3):360-370
Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis
Smyrke N; Dunn N; Murley C; Mason D
Thesis / dissertation: 2021
Immunogenicity of biological therapies : frequency, predictability and clinical relevance in chronic inflammatory diseases
Dunn, Nicky
Review: SEIZURE. 2018;54:33-40
The Viral Hypothesis of Mesial Temporal Lobe Epilepsy - Is Human Herpes Virus-6 the Missing Link? A systematic review and meta-analysis
Wipfler P; Dunn N; Beiki O; Trinka E; Fogdell-Hahn A

Employments

Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2023-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2021

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI